The Priority Review

Tag

Rhythm Pharmaceuticals

1 story

Stories

  1. Clinical trials

    Rhythm posts results of Phase 3 setmelanotide trial in genetic obesity

    The study enrolled 296 participants and completed primary data collection on December 19, 2025. Results were first posted on ClinicalTrials.gov on November 12, 2026.